Identification of myxobacteria-derived HIV inhibitors by a high-throughput two-step infectivity assay

Por Martinez, Javier P, Hinkelmann, Bettina, Fleta-Soriano, Eric, Steinmetz, Heinrich, Jansen, Rolf, Diez, Juana, Frank, Ronald, Sasse, Florenz, Meyerhans, Andreas
Publicado em 2013

The myxobacterial metabolite ratjadone A inhibits HIV infection by blocking the Rev/CRM1-mediated nuclear export pathway

Por Fleta-Soriano, Eric, Martinez, Javier P, Hinkelmann, Bettina, Gerth, Klaus, Washausen, Peter, Diez, Juana, Frank, Ronald, Sasse, Florenz, Meyerhans, Andreas
Publicado em 2014

The Myxobacterial Metabolite Soraphen A Inhibits HIV-1 by Reducing Virus Production and Altering Virion Composition

Por Fleta-Soriano, Eric, Smutná, Katarína, Martínez, Javier P., Lorca Oró, Cristina, Sadiq, S. Kashif, Mirambeau, Gilles, Lopez-Iglesias, Carmen, Bosch, Marta, Pol, Albert, Brönstrup, Mark, Diez, Juana, Meyerhans, Andreas
Publicado no Antimicrob Agents Chemother (2017)